Correlation Between Sellas Life and Edgewise Therapeutics

Can any of the company-specific risk be diversified away by investing in both Sellas Life and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sellas Life and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sellas Life Sciences and Edgewise Therapeutics, you can compare the effects of market volatilities on Sellas Life and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sellas Life with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sellas Life and Edgewise Therapeutics.

Diversification Opportunities for Sellas Life and Edgewise Therapeutics

-0.7

Correlation Coefficient

Sellas Life  Edgewise Therapeutics

Excellent diversification

The 3 months correlation between Sellas and Edgewise is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Sellas Life Sciences and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Sellas Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sellas Life Sciences are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Sellas Life i.e., Sellas Life and Edgewise Therapeutics go up and down completely randomly.

Pair Corralation between Sellas Life and Edgewise Therapeutics

Considering the 90-day investment horizon Sellas Life Sciences is expected to generate 1.97 times more return on investment than Edgewise Therapeutics. However, Sellas Life is 1.97 times more volatile than Edgewise Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Edgewise Therapeutics is currently generating about -0.02 per unit of risk. If you would invest  172.00  in Sellas Life Sciences on May 6, 2025 and sell it today you would lose (13.00) from holding Sellas Life Sciences or give up 7.56% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Sellas Life Sciences  vs.  Edgewise Therapeutics

Sellas Life Sciences

Risk-Adjusted Performance

Weak

Over the last 90 days Sellas Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Sellas Life is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Edgewise Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Edgewise Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Edgewise Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Sellas Life and Edgewise Therapeutics

The main advantage of trading using opposite Sellas Life and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sellas Life position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.

The idea behind Sellas Life Sciences and Edgewise Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.